Our Services
Preclinical Strategy Services for Biotech
From first assessment through IND-enabling and beyond. Strategy diagnostics, study-by-study roadmaps, portfolio assessments, investor readiness, buy-side diligence, and fractional preclinical leadership.
All Services
Find the Right Engagement
Each service is scoped to a specific need and stage. Every engagement starts with a complimentary Strategy Call.
Preclinical Roadmap
2-4 weeks
Signature engagement: a diligence-grade, study-by-study development plan from discovery through IND-enabling with models, endpoints, timelines, and budgets.
Learn moreStrategy Diagnostic
1-2 weeks
Stress-test your existing plan or get an initial assessment of preclinical readiness, competitive positioning, and strategic gaps.
Learn morePortfolio Assessment
2-4 weeks
Multi-program prioritization at study level. Scientific rationale, competitive landscape, preclinical feasibility, and resource allocation recommendations.
Learn moreDiligence Readiness
2-4 weeks
Investor and partner preparation package. Data room organization, mock diligence, Q&A guide, gap analysis, and readiness scorecard.
Learn moreBuy-Side Diligence
48 hours - 4 weeks
Independent preclinical assessment for VCs and pharma BD teams. Rapid Screen or full Diligence Memo with competitive positioning and risk register.
Learn moreAdvisory & Fractional
Monthly or ongoing
Embedded senior preclinical leadership. Strategy calls, protocol review, CRO oversight, board materials, and CEO/CSO strategy sessions.
Learn moreSignature Engagement
What the Roadmap Includes
Four integrated components, delivered as one cohesive plan.
Unmet Need & Positioning
- Target rationale and indication selection
- Competitive landscape analysis
- Differentiation and strategic case
- Market opportunity assessment
Study-by-Study Plan
- Model selection with rationale
- Endpoint design and success criteria
- Timeline with milestones
- Budget with quarterly capital requirements
- CRO shortlists and recommendations
- Biomarker strategy
Regulatory Path
- IND/CTA regulatory strategy
- Dose rationale (MABEL/NOAEL framework)
- Pre-IND meeting strategy
- Nonclinical submission strategy and IND section outline
Diligence-Grade Deliverables
- Visual timeline with milestones
- Risk assessment with mitigation plans
- Gap analysis
- Executive summary for board and investors
Entry Points
Not Ready for a Full Roadmap? Start Here.
Lower-commitment entry points that build toward the Roadmap.
Strategy Diagnostic
1-2 weeks
A focused assessment of where your program stands: preclinical readiness, competitive positioning, and strategic gaps. Tells you exactly what to prioritize next. Delivered with a study plan, visual timeline, budget table, risk summary, and executive summary.
Study Design Review
5-7 business days
Independent protocol review before you commit to a CRO study. Covers model selection, study design, endpoints, controls, statistical approach, and regulatory alignment. Specific recommendations with rationale.
We'll recommend the right starting point for your situation
Which Engagement Fits Your Stage?
Different stages need different things. Here's how our services map to where you are.
| Stage | What You Need | Recommended Engagement |
|---|---|---|
| Pre-Seed / Spinout | Is this developable? What would a preclinical program look like? | Strategy Diagnostic |
| Seed | Already have a strategy? Stress-test it before spending more runway. | Strategy DiagnosticorPreclinical Roadmap |
| Series A | Full plan from current data through IND-enabling. | Preclinical Roadmap |
| Series A (Multi-Program) | Which program gets resources first? | Portfolio Assessment |
| Pre-Fundraise / Pre-Partner | Preclinical story ready for investor or pharma diligence. | Diligence Readiness |
| Seed - Series A | Senior preclinical judgment without a full-time hire. | Advisory & Fractional |
Not sure where you fit? Book a Strategy Call and we'll recommend the right starting point.
Supporting Engagements
Additional services for multi-program companies, investors, and teams that need ongoing support.
For Multi-Program Companies
Portfolio Assessment
2-4 weeks
Program-by-program assessment at study level. Scientific rationale, competitive landscape, preclinical feasibility, and commercial potential. Next-study plan per program, prioritization recommendation, portfolio budget and timeline, and board narrative.
Diligence Readiness Package
2-4 weeks
Complete preclinical story for investors and partners. Data room organization, mock diligence sessions, 35+ Q&A guide, gap analysis, TPP assessment, readiness scorecard, and investor/pharma profile matching.
For Investors
Buy-Side Diligence
48 hours - 4 weeks
Independent preclinical assessment for VCs and pharma BD teams. Rapid Screen (48-hour go/watch/pass memo) for active deal flow, or full Diligence Memo (2-4 weeks) with competitive positioning, risk register, and key questions for management.
Ongoing Support
Advisory
Monthly or bi-weekly
Ongoing strategic guidance for teams navigating preclinical decisions in real time. Protocol and study report review with written comments, regular strategy calls, email access for time-sensitive questions, and quarterly program review documents.
Fractional Head of Preclinical Strategy
Ongoing
Embedded senior leadership for your preclinical program. CRO oversight and study design input, board materials, risk register management, CEO/CSO strategy sessions, nonclinical regulatory writing, and vendor relationship management.
Preview what you receive for each engagement type
How We Reduce Your Risk
You know exactly what you're getting, what it costs, and what it covers before you commit.
Clear scope, timeline, and pricing before you commit
Presentation-ready deliverables with visual timelines and budget tables
Complimentary Strategy Call to assess fit before any engagement
Deep-Dive Guides
Free resources to help you navigate preclinical development decisions.
IND-Enabling Studies Guide
Every component of the IND-enabling preclinical package
18 min read
Pre-IND Meeting Guide
How to prepare for and maximize your FDA interaction
16 min read
CRO Selection Guide
Evaluation criteria, red flags, and contract negotiation
20 min read
Fractional Head of Preclinical
Full-time hire vs. fractional leadership for early-stage biotech
14 min read
Frequently Asked Questions
Common questions about the Roadmap, diagnostics, and how to get started.
Ready to Build Your Development Plan?
Book a Strategy Call. Complimentary, 30 minutes, no obligation. We'll discuss your program and recommend the right starting point.
Book a Strategy Call30-minute call · No obligation · Confidential
info@bridgelinetranslational.com · bridgelinetranslational.com